These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 111281)

  • 21. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 22. Lithium effects on estrogen-induced dopaminergic supersensitivity in rats.
    Dorce VA; Palermo-Neto J
    Brain Res Bull; 1992 Aug; 29(2):239-41. PubMed ID: 1525677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of apomorphine to induce dopaminergic hypersensitivity: a replication.
    Flemenbaum A
    Prog Clin Biol Res; 1981; 68():143-9. PubMed ID: 7197786
    [No Abstract]   [Full Text] [Related]  

  • 24. Sedative effects of apomorphine in an animal model of Huntington's disease.
    Sanberg PR; Lehmann J; Fibiger HC
    Arch Neurol; 1979 Jun; 36(6):349-50. PubMed ID: 156535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
    Helmeste DM
    Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tonic immobility: effects of dopamine receptor blockade and stimulation.
    Wallnau LB; Carnrike CL; Dewey GI
    Pharmacol Biochem Behav; 1979 Feb; 10(2):177-81. PubMed ID: 572054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible role of dopamine in central effects of cocaine as measured by apomorphine gnawing test in mice.
    Dadkar NK; Dohadwalla AN; Bhattacharya BK
    Psychopharmacology (Berl); 1977 Apr; 52(2):115-7. PubMed ID: 407594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlated asymmetries in striatal D1 and D2 binding: relationship to apomorphine-induced rotation.
    Glick SD; Lyon RA; Hinds PA; Sowek C; Titeler M
    Brain Res; 1988 Jul; 455(1):43-8. PubMed ID: 2970881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of bradykinin on central dopamine receptors.
    Przesmycki K; Kleinrok Z
    Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-dopa causes an acute, partial and reversible reversal of denervation-induced supersensitivity of striatal dopaminergic receptors.
    Ferre S; Casas M; Cobos A; Garcia C; Jane F; Grau JM
    Psychopharmacology (Berl); 1987; 91(2):254-6. PubMed ID: 3107042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density.
    Csernansky JG; Csernansky CA; Glick SA; Hollister LE
    Psychopharmacol Bull; 1985; 21(3):707-11. PubMed ID: 2930865
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
    Broekkamp CL
    Life Sci; 1982 Dec; 31(25):2913-20. PubMed ID: 6891741
    [No Abstract]   [Full Text] [Related]  

  • 39. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
    Mattingly BA; Caudill A; Abel M
    Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.